Alimera Sciences Stock
Price
Target price
-
-
-
-
-
?8.28
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Alimera Sciences Stock
Our community is currently high on Alimera Sciences with 4 Buy predictions and 0 Sell predictions.
With a target price of 8 € there is a hugely positive potential of 94.29% for Alimera Sciences compared to the current price of 4.12 €.
Pros and Cons of Alimera Sciences in the next few years
Pros
?
G***** c******* t* c**********
?
M***** P*******
?
S********** s********
Cons
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Alimera Sciences vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Alimera Sciences | - | - | - | - | - | - | - |
Gritstone Oncology Inc | -6.610% | -4.678% | -6.857% | 6.722% | 31.593% | -73.850% | - |
Rockwell Medical Inc. | 1.330% | 9.901% | 25.121% | -6.386% | -12.795% | -85.658% | -97.163% |
Innoviva Inc. | 0.700% | 2.899% | -0.699% | 36.538% | -2.740% | 42.000% | - |
Comments
Alimera Sciences, Inc. (NASDAQ: ALIM) is now covered by analysts at Maxim Group. They set a "buy" rating and a $10.00 price target on the stock.
Show more
Ratings data for ALIM provided by MarketBeat
Alimera Sciences, Inc. (NASDAQ: ALIM) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $5.00 price target on the stock.
Show more
Ratings data for ALIM provided by MarketBeat
Alimera Sciences, Inc. (NASDAQ: ALIM) was upgraded by analysts at Alliance Global Partners from a "neutral" rating to a "buy" rating.
Show more
Ratings data for ALIM provided by MarketBeat